Glucosylsphingosine Induces Itch-Scratch Responses in Mice |
Kim, Hyoung-June
(AmorePacific Corporation)
Kim, Kwang-Mi (AmorePacific Corporation) Noh, Min-Soo (AmorePacific Corporation) Yoo, Hye-Jin (National Cancer Center) Lee, Chang-Hoon (Department of Life Science, Dongguk University) |
1 | Okamoto, R., Arikawa, J., Ishibashi, M., Kawashima, M.,Takagi, Y. and Imokawa, G. (2003). Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis. J. Lipid Res. 44, 93-102. DOI |
2 | Orvisky, E., Park, J. K., LaMarca, M. E., Ginns, E. I., Martin, B.M., Tayebi, N. and Sidransky, E. (2002). Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype. Mol. Genet. Metab. 76, 262-270. DOI |
3 | Palmer, C. N., Irvine, A. D., Terron-Kwiatkowski, A., Zhao, Y.,Liao, H., Lee, S. P., Goudie, D. R., Sandilands, A., Campbell,L. E., Smith, F. J., O'Regan, G. M., Watson, R. M., Cecil, J.E., Bale, S. J., Compton, J. G., DiGiovanna, J. J., Fleckman,P., Lewis-Jones, S., Arseculeratne, G., Sergeant, A., Munro,C. S., El Houate, B., McElreavey, K., Halkjaer, L. B.,Bisgaard, H., Mukhopadhyay, S. and McLean, W. H. (2006).Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 38, 441-446. DOI |
4 | Purcell, W. M., Cohen, D. L. and Hanahoe, T. H. (1989).Comparison of histamine and 5-hydroxytryptamine content and secretion in rat mast cells isolated from different anatomical locations. Int. Arch. Allergy Appl. Immunol. 90,382-386. DOI |
5 | Stander, S. and Steinhoff, M. (2002). Pathophysiology of pruritus in atopic dermatitis: an overview. Exp. Dermatol. 11, 12-24. DOI |
6 | Suh, H. W., Chung, K. M., Kim, Y. H., Huh, S. O. and Song, D.K. (1999). Effects of histamine receptor antagonists injected intrathecally on antinociception induced by opioids administered intracerebroventricularly in the mouse. Neuropeptides 33, 121-129. DOI |
7 | Yosipovitch, G., Greaves, M. W. and Schmelz, M. (2003). Itch. Lancet 361, 690-694. DOI |
8 | Kim, H. J., Kim, H., Han, E. S., Park, S. M., Koh, J. Y., Kim, K.M., Noh, M. S., Kim, J. J. and Lee, C. H. (2008c). Characterizations of sphingosylphosphorylcholine-induced scratching responses in ICR mice using naltrexon, capsaicin, ketotifen and Y-27632. Eur. J. Pharmacol. 583, 92-96. DOI |
9 | Leung, D. Y. and Bieber, T. (2003). Atopic dermatitis. Lancet361, 151-160. DOI |
10 | Lloyd-Evans, E., Pelled, D., Riebeling, C., Bodennec, J., de-Morgan, A., Waller, H., Schiffmann, R. and Futerman, A. H.(2003). Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms. J. Biol. Chem. 278, 23594-23599. DOI |
11 | Lorette, G. and Vaillant, L. (1990). Pruritus. Current concepts in pathogenesis and treatment. Drugs 39, 218-223. DOI |
12 | Meyer zu Heringdorf, D. and Jakobs, K. H. (2007). Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. Biochim. Biophys. Acta.1768, 923-940. DOI |
13 | Nilsson, O. and Svennerholm, L. (1982). Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease. J. Neurochem. 39, 709-718. DOI |
14 | Kim, D. K., Kim, H. J., Kim, H., Koh, J. Y., Kim, K. M., Noh, M.S., Kim, J. J. and Lee, C. H. (2008a). Involvement of serotonin receptors 5-HT1 and 5-HT2 in 12(S)-HPETE-induced scratching in mice. Eur. J. Pharmacol. 579, 390-394. DOI |
15 | Kim, H. J., Kim, D. K., Kim, H., Koh, J. Y., Kim, K. M., Noh, M.S., Lee, S., Kim, S., Park, S. H., Kim, J. J., Kim, S. Y. andLee, C. H. (2008b). Involvement of the BLT2 receptor in the itch-associated scratching induced by 12-(S)-lipoxygenase products in ICR mice. Br. J. Pharmacol. 154, 1073-1078. DOI |
16 | Han, M., Kim, Y. L., Sacket, S. J., Kim, K., Kim, H. L., Jo, J. Y.,Ha, N. C. and Im, D. S. (2007). Effect of direct albumin binding to sphingosylphosphorylcholine in Jurkat T cells.Prostaglandins Other Lipid Mediat. 84, 174-183. DOI |
17 | Choi, H., Kim, S., Kim, H. J., Kim, K. M., Lee, C. H., Shin, J. H.and Noh, M. (2010). Sphingosylphosphorylcholine downregulates filaggrin gene transcription through NOX5- based NADPH oxidase and cyclooxygenase-2 in human keratinocytes. Biochem. Pharmacol. 80, 95-103. DOI |
18 | Cook, P. R. (1996). Seasonal allergic rhinitis. Mo. Med. 93,247-250. |
19 | Fu, L. W., Pan, H. L. and Longhurst, J. C. (1997). Endogenous histamine stimulates ischemically sensitive abdominal visceral afferents through H1 receptors. Am. J. Physiol. 273, H2726-2737. |
20 | Han, S. K., Mancino, V. and Simon, M. I. (2006). Phospholipase Cbeta 3 mediates the scratching response activated by the histamine H1 receptor on C-fiber nociceptive neurons.Neuron 52, 691-703. DOI |
21 | Hashimoto, T., Ohata, H. and Momose, K. (2004). Itch-scratch responses induced by lysophosphatidic acid in mice. Pharmacology 72, 51-56. DOI |
22 | Holzer, P. (1988). Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 24, 739-768. DOI |
23 | Imokawa, G. (2009). A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. J. Dermatol. Sci. 55, 1-9. DOI |
24 | Bienkowski, P., Kostowski, W. and Koros, E. (1999). Ethanolreinforced behaviour in the rat: effects of naltrexone. Eur. J. Pharmacol. 374, 321-327. DOI |
25 | Inagaki, N., Nakamura, N., Nagao, M., Kawasaki, H. and Nagai,H. (2000). Inhibition of passive cutaneous anaphylaxisassociated scratching behavior by mu-opioid receptor antagonists in ICR mice. Int. Arch. Allergy Immunol. 123, 365-368. DOI |
26 | Bevan, S. and Szolcsanyi, J. (1990). Sensory neuron-specific actions of capsaicin: mechanisms and applications. Trends Pharmacol. Sci. 11, 330-333. |
27 | Bielory, L., Goodman, P. E. and Fisher, E. M. (2001). Allergic ocular disease. A review of pathophysiology and clinical presentations. Clin. Rev. Allergy Immunol. 20, 183-200. DOI |